Rocket


News + Filings
Transactions
Holdings





ORBIMED ADVISORS LLC

DateNameSymbolTypeSecuritySharesPriceValueOwnershipReported
10/03/2023NeuroPace IncNPCESaleCommon Stock700$9.02$6.3kSee Footnotes10/02/2023
10/02/2023NeuroPace IncNPCESaleCommon Stock7.6k$9.08$69.1kSee Footnotes10/02/2023
08/15/2023Galecto, Inc.GLTOSaleCommon Stock38.3k$0.75$28.7kSee footnotes08/15/2023
08/15/2023Galecto, Inc.GLTOSaleCommon Stock248.8k$0.75$186.6kSee footnotes08/15/2023
08/15/2023Galecto, Inc.GLTOSaleCommon Stock535.5k$0.75$401.7kSee footnotes08/15/2023
07/31/2023Galecto, Inc.GLTOSaleCommon Stock26.6k$3.00$79.9kSee footnotes07/31/2023
07/31/2023Galecto, Inc.GLTOSaleCommon Stock29.7k$3.00$89.1kSee footnotes07/31/2023
07/31/2023Galecto, Inc.GLTOSaleCommon Stock153.1k$3.00$459.2kSee footnotes07/31/2023
07/25/2023Galecto, Inc.GLTOSaleCommon Stock7.8k$2.92$22.8kSee footnotes07/25/2023
07/25/2023Galecto, Inc.GLTOSaleCommon Stock4.7k$2.92$13.7kSee footnotes07/25/2023
07/25/2023Galecto, Inc.GLTOSaleCommon Stock26.7k$2.92$78kSee footnotes07/25/2023
07/13/2023Galecto, Inc.GLTOSaleCommon Stock9.8k$2.40$23.5kSee footnotes07/13/2023
07/13/2023Galecto, Inc.GLTOSaleCommon Stock52.8k$2.40$126.7kSee footnotes07/13/2023
07/13/2023Galecto, Inc.GLTOSaleCommon Stock132.1k$2.40$317kSee footnotes07/13/2023
06/28/2023Passage BIO, Inc.PASGPurchaseCommon Stock575.2k$0.84$483.2kSee footnotes06/27/2023
06/27/2023Adicet Bio, Inc.TORCPurchaseCommon Stock125k$2.09$261.2kSee footnotes06/27/2023
06/27/2023Adicet Bio, Inc.TORCPurchaseCommon Stock250k$2.09$522.5kSee footnotes06/27/2023
06/27/2023Adicet Bio, Inc.TORCPurchaseCommon Stock442k$2.09$923.8kSee footnotes06/27/2023
06/27/2023Adicet Bio, Inc.TORCPurchaseCommon Stock58k$2.09$121.2kSee footnotes06/27/2023
06/27/2023Passage BIO, Inc.PASGPurchaseCommon Stock617.4k$0.84$518.6kSee footnotes06/27/2023
05/22/2023Prelude Therapeutics IncPRLDPurchaseCommon Stock869.6k$5.75$5MSee footnotes05/22/2023
05/17/2023Enliven Therapeutics, Inc.IMRAExerciseStock Options (Right to Buy)2.1k$4.28$9.1kSee footnotes05/17/2023
05/15/2023Verona Pharma plcVRNASaleOrdinary Shares14.4k$21.96$316.2kSee footnotes05/11/2023
05/15/2023Verona Pharma plcVRNASaleOrdinary Shares345.3k$20.00$6.9MSee footnotes05/11/2023
05/12/2023Verona Pharma plcVRNASaleOrdinary Shares43.2k$21.64$934.8kSee footnotes05/11/2023
05/11/2023Verona Pharma plcVRNASaleOrdinary Shares80k$22.26$1.8MSee footnotes05/11/2023
05/05/2023Kinnate Biopharma Inc. PurchaseCommon Stock490.5k$2.82$1.4MSee footnotes05/04/2023
05/05/2023Kinnate Biopharma Inc. PurchaseCommon Stock490.5k$2.82$1.4MSee footnotes05/04/2023
05/04/2023Kinnate Biopharma Inc. PurchaseCommon Stock83.5k$2.75$229.5kSee footnotes05/04/2023
05/04/2023Kinnate Biopharma Inc. PurchaseCommon Stock313k$2.75$860.7kSee footnotes05/04/2023
05/04/2023Kinnate Biopharma Inc. PurchaseCommon Stock83.5k$2.75$229.5kSee footnotes05/04/2023
02/23/2023Enliven Therapeutics, Inc.IMRAGrantCommon Stock7.6M$0.00$0See footnotes02/23/2023
02/23/2023Enliven Therapeutics, Inc.IMRAGrantCommon Stock288.1k$0.00$0See footnotes02/23/2023
02/17/2023Kinnate Biopharma Inc. GrantCommon Stock550k$0.00$0See footnotes02/17/2023
02/17/2023Kinnate Biopharma Inc. GrantCommon Stock550k$0.00$0See footnotes02/17/2023
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy